Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNIF: Self-Administered Nasal Influenza Vaccine
NCT01933048Phase 4Completed
- Sponsor
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- Start
- Sep 2012
- Primary completion
- Oct 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal) in influenza, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine. Started Sep 2012; status: completed.
02
Drugs
influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01933048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01933048.